EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy

Yoko Endo-Takahashi iD, Akane Sakurai, Yukiko Oguri, Fumihiko Katagiri, Saki Akiyama, Sanae Sashida, Taiki Yamaguchi iD, Tetsuro Marunouchi, Ryo Suzuki iD, Kazuo Maruyama, Kouichi Tanonaka, Motoyoshi Nomizu iD und 1 weitere

ACS Omega · 11.03.2025 · 10 (9) · 9639-9648

DOI: 10.1021/acsomega.4c10896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 27.02.2025. Verfasst von Yoko Endo-Takahashi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Ha…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, New Energy and Industrial Technology Development Organization.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbubbles (MBs) and nanobubbles (NBs) can oscillate and collapse in response to ultrasound exposure, resulting in contrast and delivery effects. Therefore, the retention of the entrapped gas is an important condition in bubble formulations, especially for MBs and NBs with lipid shells, and the stability of the lipid membrane is considered to be affected. We previously developed NBs, which are polyethylene glycol-modified liposomes entrapping an ultrasound contrast gas that can serve as nucleic acid carriers and ultrasound contrast agents. In particular, NBs containing cationic lipids were useful as systemic delivery tools that can load genes and nucleic acids on their surfaces. However, the gas retention of NBs containing cationic lipids were low, leaving room for improvement as ultrasound contrast agents. In this study, we attempted to prepare NBs containing anionic lipids to improve their stability in vivo, and found that they lasted longer in contrast time than previous NBs. In order to utilize anionic NBs, we evaluated their usefulness as systemic delivery tools for cationic-peptide-conjugated phosphorodiamidate morpholino oligomers (PMO). PMO has attracted attention as a therapeutic agent for Duchenne muscular dystrophy (DMD); however, its charge neutrality makes its delivery into muscle fibers challenging, especially more difficult to apply PMO to myocardial damage. We examined the systemic delivery of PMO to the heart using a combination of anionic NBs and ultrasound. Furthermore, we evaluated the usability of octaarginine (R8), a cationic cell-penetrating peptide (CPP), in loading PMO onto the surface of NBs and verified the potential of PMO-loaded NBs as a therapy for cardiac dysfunction in muscular dystrophy.

Autor:innen und Institutionen

  • Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
  • Department of Clinical Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
  • Department of Molecular and Cellular Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
  • Laboratory of Drug and Gene Delivery Research, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
  • Laboratory of Theranostics, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

ORCID-Profile: Yoko Endo-Takahashi, Taiki Yamaguchi, Ryo Suzuki, Motoyoshi Nomizu, Yoichi Negishi

Förderung

  • Japan Society for the Promotion of Science
  • New Energy and Industrial Technology Development Organization

Zitieren

APA

Endo-Takahashi, Y., Sakurai, A., Oguri, Y., Katagiri, F., Akiyama, S., Sashida, S., Yamaguchi, T., Marunouchi, T., Suzuki, R., Maruyama, K., Tanonaka, K., Nomizu, M., & Negishi, Y. (2025). Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy. ACS Omega, 10(9), 9639-9648. https://doi.org/10.1021/acsomega.4c10896

Vancouver

Endo-Takahashi Y, Sakurai A, Oguri Y, Katagiri F, Akiyama S, Sashida S, et al. Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy. ACS Omega. 2025;10(9):9639-9648. doi:10.1021/acsomega.4c10896

BibTeX
@article{EndoTakahashi2025,
  author = {Endo-Takahashi, Yoko and Sakurai, Akane and Oguri, Yukiko and Katagiri, Fumihiko and Akiyama, Saki and Sashida, Sanae and Yamaguchi, Taiki and Marunouchi, Tetsuro and Suzuki, Ryo and Maruyama, Kazuo and Tanonaka, Kouichi and Nomizu, Motoyoshi and Negishi, Yoichi},
  title = {Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy},
  journal = {ACS Omega},
  year = {2025},
  volume = {10},
  number = {9},
  pages = {9639--9648},
  doi = {10.1021/acsomega.4c10896}
}
Kostenlos starten →